STOMAZE P
MEFENAMIC ACID 100 MG + PARA 250 MG SYP
Brand: STOMAZE P
MRP
₹90/-
Packaging
60 ML WITH CARTON
Form
ANALGESIC
Description & Usage
Mefenamic Acid 100 MG, Para 250 MG Syrup
Mefenamic Acid 100 MG, Para 250 MG Syp is a pharmaceutical oral liquid medicine which is being formulated by utilizing the mixture of Mefenamic Acid and Paracetamol. The combination of Mefenamic Acid and Paracetamol is holding a good market share in general medicine and pediatric range of products. Mefenamic Acid 100 mg and Paracetamol 250 mg formulation has gained the identity of a professional formulation in this product segment and also an acceptable part in an oral liquid medicine range for pharma companies.
This formulation is commonly available within the products list for companies that are dealing in PCD pharma franchise, third party manufacturing, branded medicine marketing, and pharmaceutical distribution. A syrup form is an easy way to pack, store, transfer and dispatch through different pharma networks. If manufactured with a good quality with attractive packaging and dependable supply, Mefenamic Acid 100 MG, Para 250 MG Syp can be an integral part of the product list of a professional pharma business.
Composition Profile and syrup formulation value
Each syrup form contains the combination of Mefenamic Acid 100 mg along with Paracetamol 250 mg. The component Mefenamic Acid is already recognized as an important ingredient within pain management categories while Paracetamol is widely recognized for use in various general medicines. Together these components make an effective and desirable oral liquid in the pharma market.
The syrup is generally prepared with proper excipients which help the formulation to sustain its taste, texture, viscosity, stability, homogeneity and shelf-life along with adequate product stability through time. Stabilizing agents, preservatives, sweeteners, flavorings and suspension stabilizing agents are commonly used so that the presentation of the formulation becomes appreciable. This is how a well formulated syrup can deliver the balanced combination of active pharmaceutical ingredients in each measured quantity of formulation.
Oral liquid product identity and presentation
The combination formulation, Mefenamic Acid 100 MG, Para 250 MG Syp, holds a clear product identity in the oral liquid and pediatric range of pharmaceutical preparations. Syrup forms are widely included within the products portfolio because of their good product presentation and market acceptance. This dosage form can form a part of the wider product list of companies that manufacture tablets, capsules, dry syrups, suspensions, and drops.
Moreover, this dosage form itself supports better branding strategies since a well designed label can capture maximum attention from customers. A clean bottle design, bright outer carton along with a transparent ingredient display can present this formulation as a truly professional oral liquid product in general medicine and pain relief range.
Quality manufacturing and processing standards
Mefenamic Acid 100 MG, Para 250 MG Syp requires standard manufacturing quality and manufacturing facilities. High quality raw materials are usually employed along with appropriate liquid processing machinery and controlled environment to procure a product of utmost purity, strength, stability and homogeneity. Any of the processing steps need to be handled in a controlled manner so that the formulation is of standard pharmaceutical quality.
Different quality checks like that of raw materials, syrup base processing, content uniformity of blended ingredients, viscosity test, pH monitoring, flavor testing, filling precision, final product examination and quality checks on bottle sealing and packaging can help assure the quality of the product. Since it is a dual-combination, care is taken to make the combination uniform so that the strength of both ingredients are equivalent in each measured dosage of the product.
Such an approach towards product quality has helped to improve the product value in the highly competitive pharmaceutical market and gain the confidence of many wholesalers, retailers, distributors and also PCD franchise partners.
Packaging, labeling and brand presentation
Packaging can play a critical role in protecting Mefenamic Acid 100 MG, Para 250 MG Syp and improving its brand presence. High quality bottles and closures, a measuring cup to administer precise dosage along with an attractive outer carton is essential for the product. Proper packaging not only protects the product from physical damage, leakage, and contaminants, but also increases its market appeal.
The label must bear clear information about brand name, salt content and strength, net volume of the syrup, expiry date and manufacturing date, maximum retail price (MRP), along with directions to store the product. Crisp and clear printing on the label and carton enhances the professional appearance of the brand.
For a pharma company, an outstanding package along with the good formulation gives a great edge over the other competitive brands in the general medicine or pediatric ranges. This formulation also serves as an integral part of a comprehensive product portfolio, allowing businesses to offer diverse products.
Market demand and PCD pharma franchise scope
Mefenamic Acid 100 MG, Para 250 MG Syp has high demand in the pharma market, owing to the popularity of combination oral liquids in the general medicine and pediatric drug ranges. This product is beneficial for pharma companies to consolidate their oral liquid section, especially as it involves widely accepted constituents.
Wholesalers, retailers, distributors and the PCD pharma franchise business owners find it to be an excellent addition to their portfolios due to its consistent demand and contribution to a broad selection of products. Many organizations tend to introduce this combination in their product lists to complete their entire medicine product offering, that could include everything from nutritional syrups and drops to tablets, capsules and suspensions.
The PCD pharma franchise segment also has significant potential when it comes to this formulation, since there is adequate scope for its marketing and distribution through visual aids, visual reminders and promptings, Prescription pads, MR bags, brochures and related printed materials. When combined with proper branding, quality, packaging, competitive prices, timely delivery and dependable supply, Mefenamic Acid 100 MG, Para 250 MG Syp proves itself to be an asset in any professional pharma franchise business's product line.
Mefenamic Acid 100 MG, Para 250 MG Syrup
Mefenamic Acid 100 MG, Para 250 MG Syp is a pharmaceutical oral liquid medicine which is being formulated by utilizing the mixture of Mefenamic Acid and Paracetamol. The combination of Mefenamic Acid and Paracetamol is holding a good market share in general medicine and pediatric range of products. Mefenamic Acid 100 mg and Paracetamol 250 mg formulation has gained the identity of a professional formulation in this product segment and also an acceptable part in an oral liquid medicine range for pharma companies.
This formulation is commonly available within the products list for companies that are dealing in PCD pharma franchise, third party manufacturing, branded medicine marketing, and pharmaceutical distribution. A syrup form is an easy way to pack, store, transfer and dispatch through different pharma networks. If manufactured with a good quality with attractive packaging and dependable supply, Mefenamic Acid 100 MG, Para 250 MG Syp can be an integral part of the product list of a professional pharma business.
Composition Profile and syrup formulation value
Each syrup form contains the combination of Mefenamic Acid 100 mg along with Paracetamol 250 mg. The component Mefenamic Acid is already recognized as an important ingredient within pain management categories while Paracetamol is widely recognized for use in various general medicines. Together these components make an effective and desirable oral liquid in the pharma market.
The syrup is generally prepared with proper excipients which help the formulation to sustain its taste, texture, viscosity, stability, homogeneity and shelf-life along with adequate product stability through time. Stabilizing agents, preservatives, sweeteners, flavorings and suspension stabilizing agents are commonly used so that the presentation of the formulation becomes appreciable. This is how a well formulated syrup can deliver the balanced combination of active pharmaceutical ingredients in each measured quantity of formulation.
Oral liquid product identity and presentation
The combination formulation, Mefenamic Acid 100 MG, Para 250 MG Syp, holds a clear product identity in the oral liquid and pediatric range of pharmaceutical preparations. Syrup forms are widely included within the products portfolio because of their good product presentation and market acceptance. This dosage form can form a part of the wider product list of companies that manufacture tablets, capsules, dry syrups, suspensions, and drops.
Moreover, this dosage form itself supports better branding strategies since a well designed label can capture maximum attention from customers. A clean bottle design, bright outer carton along with a transparent ingredient display can present this formulation as a truly professional oral liquid product in general medicine and pain relief range.
Quality manufacturing and processing standards
Mefenamic Acid 100 MG, Para 250 MG Syp requires standard manufacturing quality and manufacturing facilities. High quality raw materials are usually employed along with appropriate liquid processing machinery and controlled environment to procure a product of utmost purity, strength, stability and homogeneity. Any of the processing steps need to be handled in a controlled manner so that the formulation is of standard pharmaceutical quality.
Different quality checks like that of raw materials, syrup base processing, content uniformity of blended ingredients, viscosity test, pH monitoring, flavor testing, filling precision, final product examination and quality checks on bottle sealing and packaging can help assure the quality of the product. Since it is a dual-combination, care is taken to make the combination uniform so that the strength of both ingredients are equivalent in each measured dosage of the product.
Such an approach towards product quality has helped to improve the product value in the highly competitive pharmaceutical market and gain the confidence of many wholesalers, retailers, distributors and also PCD franchise partners.
Packaging, labeling and brand presentation
Packaging can play a critical role in protecting Mefenamic Acid 100 MG, Para 250 MG Syp and improving its brand presence. High quality bottles and closures, a measuring cup to administer precise dosage along with an attractive outer carton is essential for the product. Proper packaging not only protects the product from physical damage, leakage, and contaminants, but also increases its market appeal.
The label must bear clear information about brand name, salt content and strength, net volume of the syrup, expiry date and manufacturing date, maximum retail price (MRP), along with directions to store the product. Crisp and clear printing on the label and carton enhances the professional appearance of the brand.
For a pharma company, an outstanding package along with the good formulation gives a great edge over the other competitive brands in the general medicine or pediatric ranges. This formulation also serves as an integral part of a comprehensive product portfolio, allowing businesses to offer diverse products.
Market demand and PCD pharma franchise scope
Mefenamic Acid 100 MG, Para 250 MG Syp has high demand in the pharma market, owing to the popularity of combination oral liquids in the general medicine and pediatric drug ranges. This product is beneficial for pharma companies to consolidate their oral liquid section, especially as it involves widely accepted constituents.
Wholesalers, retailers, distributors and the PCD pharma franchise business owners find it to be an excellent addition to their portfolios due to its consistent demand and contribution to a broad selection of products. Many organizations tend to introduce this combination in their product lists to complete their entire medicine product offering, that could include everything from nutritional syrups and drops to tablets, capsules and suspensions.
The PCD pharma franchise segment also has significant potential when it comes to this formulation, since there is adequate scope for its marketing and distribution through visual aids, visual reminders and promptings, Prescription pads, MR bags, brochures and related printed materials. When combined with proper branding, quality, packaging, competitive prices, timely delivery and dependable supply, Mefenamic Acid 100 MG, Para 250 MG Syp proves itself to be an asset in any professional pharma franchise business's product line.